Lanreotide
Also known as: somatuline, lanreotide acetate, somatostatin analogue lanreotide
Somatostatin analogue studied for acromegaly, neuroendocrine tumors, and GH suppression.
Quick Reference
Lanreotide - Research Images
PSO vial render · Scientific images from Wikipedia · Tap to enlarge
Overview
Pharmaceutical drug
Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.
Mechanism of Action
Lanreotide, sold under the brand name Somatuline among others, is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.
What Researchers Are Saying
Community Reports - Not Medical Advice
The following is aggregated from public forums, Reddit, and research communities. These are anecdotal reports from researchers only - not verified clinical data and not a recommendation of any kind.
Lanreotide (also known as somatuline, lanreotide acetate) is studied within the peptide research community. Somatostatin analogue studied for acromegaly, neuroendocrine tumors, and GH suppression.
Last updated October 28, 2026
Research status: active. Lanreotide appears across peptide research forums and academic literature. Researchers note this compound falls in the other category.
Last updated October 28, 2026
What Do You Think of This Peptide?
Share your opinion or research experience with Lanreotide. Comments are reviewed before appearing.